CSTEVSNRSN• 6 Months (Normalized)
CSTE vs NRSN (Caesarstone Ltd. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Apr 2 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CSTE Performance $2.87
+%
Caesarstone Ltd.
Normalized Baseline0.00%
NRSN Performance $4.78
+475.9%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-475.9 pts
NRSN outperforming by 475.90 percentage points
CSTENRSN
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CSTE NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | CSTE Price | CSTE Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $4.78 | +475.90% | - | |
| Sep 28, 2026 | $2.87 | +158.56% | $5.10 | +514.46% | -355.90% |
| Sep 25, 2026 | $2.94 | +164.86% | $6.95 | +737.35% | -572.49% |
| Sep 24, 2026 | $3.00 | +170.27% | $7.40 | +791.57% | -621.30% |
| Sep 23, 2026 | $2.79 | +151.35% | $7.40 | +791.57% | -640.22% |
| Sep 22, 2026 | $2.83 | +154.95% | $7.18 | +765.06% | -610.11% |
| Sep 21, 2026 | $2.77 | +149.55% | $6.62 | +697.59% | -548.04% |
| Sep 18, 2026 | $2.87 | +158.56% | $6.35 | +665.06% | -506.50% |
| Sep 17, 2026 | $2.81 | +153.15% | $6.72 | +709.64% | -556.49% |
| Sep 16, 2026 | $2.87 | +158.56% | $6.49 | +681.93% | -523.37% |
| Sep 15, 2026 | $3.01 | +171.17% | $7.03 | +746.99% | -575.82% |
| Sep 14, 2026 | $3.13 | +181.98% | $6.90 | +731.33% | -549.35% |
| Sep 11, 2026 | $3.19 | +187.39% | $0.35 | -58.19% | +245.58% |
| Sep 10, 2026 | $3.18 | +186.49% | $0.33 | -60.00% | +246.49% |
| Sep 09, 2026 | $3.01 | +171.17% | $0.40 | -51.69% | +222.86% |
Page 1 of 9